Blue Cross Faces $421M Fraud Verdict Over Unpaid Cancer Claims

---

Full Story

A jury has awarded a medical practice $421 million, ruling Blue Cross committed fraud by refusing to fully pay doctors’ bills for cancer treatments while approving special deals for executives’ wives.

Blue Cross authorized mastectomies and breast reconstructions for cancer patients. However, it consistently declined to cover the full cost of these procedures.

MEDIA REPORTING

See how news sources on all sides are covering this story.

Left 43% | Right 23% | Center 29% | Unrated 6%

The Context

The trial exposed a pattern of selective payment practices by the insurer. Executives secured one-time agreements to fund their spouses’ treatments at the same center.

The medical practice argued Blue Cross wielded undue power over doctors’ reimbursements. This led to significant financial strain for the center’s operations.

The jury’s verdict labeled the insurer’s actions as fraudulent. The $421 million award aims to address the unpaid claims and punitive damages.

Patients at the center faced delays and uncertainty due to denied claims. Many relied on the practice for critical, life-saving care.

The case highlights tensions between healthcare providers and insurance companies. It underscores the impact of payment disputes on patient care.

Some support the verdict, arguing it holds insurers accountable for fair practices. Others worry it could raise premiums or strain insurer-doctor relations.